Literature DB >> 33258147

Simple Synthesis of a Heterocyclophane Exhibiting Anti-c-Met Activity by Acting as a Hatch Blocking Access to the Active Site*.

Tatsuya Takimoto1, Hideaki Sasaki1, Hirohito Tsue2, Hiroki Takahashi2, Alexander D MacKerell3, Ayumi Nakamura1, Katsuya Nakano1, Eori Okazaki1, Tatsuki Betsuyaku1, Ryosuke Tachibana1, Kazuhito Hioki1, Ozge Yoluk3, Sunhwan Jo4.   

Abstract

A simple approach to the synthesis of heterocyclophane consisting of two 4,4'-bithiazoles has been developed in mild conditions. The heterocyclophane with two short chains was conveniently prepared by Hantzsch thiazoles synthesis using the reaction of 3-tert-butoxycarbonyl-3-azapentanethiocarboxamide with 1,4-dibromobutane-2,3-dione in methanol under reflux for only 15 min. Amino groups at the linkers of this heterocyclophane can be functionalized to give acylated and carbamate derivatives. Their properties as protein kinase inhibitors were investigated, and one of the heterocyclophanes exhibited specific anti-activity for c-mesenchymal epithelial transition factor (IC50 =603 nm), among seven types of protein kinases investigated. The computational site identification by ligand competitive saturation method was used to determine why the one heterocyclophane exhibited strong anti-activity for c-mesenchymal epithelial transition factor.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  computational chemistry; cyclophanes; drug design; inhibitors; synthetic design

Year:  2020        PMID: 33258147      PMCID: PMC7887132          DOI: 10.1002/chem.202001382

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  21 in total

1.  Insights into the mechanism of microtubule stabilization by Taxol.

Authors:  Hui Xiao; Pascal Verdier-Pinard; Narcis Fernandez-Fuentes; Berta Burd; Ruth Angeletti; Andras Fiser; Susan Band Horwitz; George A Orr
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

Review 2.  Biology of MET: a double life between normal tissue repair and tumor progression.

Authors:  Iacopo Petrini
Journal:  Ann Transl Med       Date:  2015-04

3.  Erlotinib in previously treated non-small-cell lung cancer.

Authors:  Frances A Shepherd; José Rodrigues Pereira; Tudor Ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

4.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility.

Authors:  M Stoker; E Gherardi; M Perryman; J Gray
Journal:  Nature       Date:  1987 May 21-27       Impact factor: 49.962

5.  Chemistry of bleomycin. XXII. Interaction of bleomycin with nucleic acids, preferential binding to guanine base and electrostatic effect of the terminal amine.

Authors:  H Kasai; H Naganawa; T Takita; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1978-12       Impact factor: 2.649

6.  Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

Authors:  Patrick C Ma; Ramasamy Jagadeeswaran; Simha Jagadeesh; Maria S Tretiakova; Vidya Nallasura; Edward A Fox; Mark Hansen; Erik Schaefer; Katsuhiko Naoki; Alan Lader; William Richards; David Sugarbaker; Aliya N Husain; James G Christensen; Ravi Salgia
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

7.  Reproducing crystal binding modes of ligand functional groups using Site-Identification by Ligand Competitive Saturation (SILCS) simulations.

Authors:  E Prabhu Raman; Wenbo Yu; Olgun Guvench; Alexander D Mackerell
Journal:  J Chem Inf Model       Date:  2011-04-01       Impact factor: 4.956

8.  Molecular cloning and expression of human hepatocyte growth factor.

Authors:  T Nakamura; T Nishizawa; M Hagiya; T Seki; M Shimonishi; A Sugimura; K Tashiro; S Shimizu
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

9.  HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors.

Authors:  S Gusenbauer; P Vlaicu; A Ullrich
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

10.  Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.

Authors:  Xueyan Wang; Phuong Le; Congxin Liang; Julie Chan; David Kiewlich; Todd Miller; Dave Harris; Li Sun; Audie Rice; Stefan Vasile; Robert A Blake; Anthony R Howlett; Neela Patel; Gerald McMahon; Kenneth E Lipson
Journal:  Mol Cancer Ther       Date:  2003-11       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.